Language performance in Alzheimer's disease and mild cognitive impairment: A comparative review

  title={Language performance in Alzheimer's disease and mild cognitive impairment: A comparative review},
  author={Vanessa Taler and Natalie A. Phillips},
  journal={Journal of Clinical and Experimental Neuropsychology},
  pages={501 - 556}
  • V. Taler, N. Phillips
  • Published 4 June 2008
  • Psychology
  • Journal of Clinical and Experimental Neuropsychology
Mild cognitive impairment (MCI) manifests as memory impairment in the absence of dementia and progresses to Alzheimer's disease (AD) at a rate of around 15% per annum, versus 1–2% in the general population. It thus constitutes a primary target for investigation of early markers of AD. Language deficits occur early in AD, and performance on verbal tasks is an important diagnostic criterion for both AD and MCI. We review language performance in MCI, compare these findings to those seen in AD, and… 
The Impact of Cognitive Training in Mild Cognitive Impairment and Early Stage Alzheimer’s Disease. A Selective Review
Importance: Patients with Alzheimer’s disease (AD) and a substantial portion of patients with Mild Cognitive Impairment (MCI) present prominent language deficits that usually appear earlier than
Connected speech and language in mild cognitive impairment and Alzheimer’s disease: A review of picture description tasks
Picture description tasks are useful tools for detecting differences in a wide variety of language and communicative measures and future research should expand knowledge about subtle changes to language in preclinical AD and Mild Cognitive Impairment (MCI) which may improve the utility of this method as a clinically meaningful screening tool.
Using Cognitive Models to Investigate the Temporal Dynamics of Semantic Memory Impairments in the Development of Alzheimer’s Disease
A computational model that uses multiple types of lexical information in conjunction with a standard memory search process was able to successfully differentiate changes in semantic memory processing for individuals who develop MCI, even when behavioral variables could not.
Could language deficits really differentiate Mild Cognitive Impairment (MCI) from mild Alzheimer's disease?
Differentiating Mild Cognitive Impairment and Cognitive Changes of Normal Aging
This chapter will focus on a pragmatic approach to differentiating MCI from normal aging.
Language Performance of Individuals at Risk for Mild Cognitive Impairment.
Language performance deficits can appear early before impairment in episodic memory, visuospatial construction ability, or mental status in individuals at risk for MCI and speech-language pathologists are uniquely qualified to identify subtle changes in language.
Language in Amnestic Mild Cognitive Impairment and Dementia of Alzheimer’s Type: Quantitatively or Qualitatively Different?
Background/Aims: The purpose of this study was to explore language differences between individuals diagnosed with amnestic mild cognitive impairment multiple domain (aMCIm) and those with probable
Cognitive and Structural Correlates of Conversational Speech Timing in Mild Cognitive Impairment and Mild-to-Moderate Alzheimer’s Disease: Relevance for Early Detection Approaches
The implementation of conversational speech timing-based technologies in clinical and community settings may provide additional markers for the early detection of cognitive deficits and structural changes associated with MCI and AD.
Sensitive Measures of Cognition in Mild Cognitive Impairment.
These experimental measures appear sensitive to cognitive change and neurodegeneration early in the AD trajectory and may prove useful in tracking cognitive change in clinical trials aimed at early intervention.


Neuropsychological Deficit in Early Subcortical Vascular Dementia: Comparison to Alzheimer’s Disease
The results of retrieval deficit syndrome and increased number of perseverations during tasks sensitive to frontal lobe function are in agreement with the studies emphasizing the importance of frontal dysfunction in subcortical vascular dementia.
Cognitive Profiles in Alzheimer’s Disease and in Mild Cognitive Impairment of Different Etiologies
Analysis of cognitive profiles of nondemented patients with MCI diagnosed with prodromal Alzheimer’s disease and those diagnosed with vascular disease found that both groups could be distinguished from dementia patients with regards to performance on measures of memory but not on non-memory measures.
Clinical diagnosis of Alzheimer's disease
The criteria proposed are intended to serve as a guide for the diagnosis of probable, possible, and definite Alzheimer's disease; these criteria will be revised as more definitive information becomes available.
Mild cognitive impairment in different functional domains and incident Alzheimer’s disease
Among persons with mild cognitive impairment, episodic memory impairment is associated with a substantial and persistent elevation in risk of developing AD compared to impairment in other cognitive systems.
Neuropsychological Markers of Progression From Mild Cognitive Impairment to Alzheimer’s Disease
To find early clinical markers that may predict a likely progression to Alzheimer’s disease (AD), the authors performed neuropsychological tests on 82 mild cognitive impairment (MCI) subjects and found the CAMCOG Memory and Perception cognitive screening items were the optimum independent tools to classify the patients who will progress to AD.
Mild Cognitive Impairment: An Operational Definition and Its Conversion Rate to Alzheimer’s Disease
MCI is an accurate predictor of AD over 1 and 2 years in patients referred by their primary care physicians in patients identified from an inception cohort of patients with at least a 3-month history of memory problems.
Early Detection and Differential Diagnosis of Alzheimer’s Disease and Depression with Neuropsychological Tasks
A visuo-spatial associative learning test accurately distinguished AD from depressed/control subjects and revealed an apparent sub-group of QD patients who performed like AD patients, correlated with the degree of subsequent global cognitive decline.
Mild cognitive impairment: new neuropsychological and pharmacological target.